Staphylococcus aureus protein A enhances osteoclastogenesis via TNFR1 and EGFR signaling

Staphylococcus aureus is a major causative agent of osteomyelitis in adults and children. The increasing incidence of antimicrobial resistant isolates and the morbidity of this type of infection denote that alternative therapeutic approaches are required. S. aureus protein A interacts with TNFR1 and...

Descripción completa

Detalles Bibliográficos
Autores: Mendoza Bertelli, Andrea Cristina, Delpino, María Victoria, Lattar, Santiago Martín, Giai, Constanza, Noto Llana, Mariangeles, Sanjuan, Norberto Aníbal, Cassat, James E., Sordelli, Daniel Oscar, Gomez, Marisa Ines
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/51112
Acceso en línea:http://hdl.handle.net/11336/51112
Access Level:acceso abierto
Palabra clave:EGFR
OSTEOCLASTOGENESIS
PROTEIN A
STAPHYLOCOCCUS AUREUS
TNFR1
https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
Descripción
Sumario:Staphylococcus aureus is a major causative agent of osteomyelitis in adults and children. The increasing incidence of antimicrobial resistant isolates and the morbidity of this type of infection denote that alternative therapeutic approaches are required. S. aureus protein A interacts with TNFR1 and EGFR expressed at the surface of host cells. Given the importance of TNF-α and EGFR/RANKL crosstalk in enhancing osteoclast differentiation, the aim of this study was to determine the role of protein A in the induction of osteoclastogenesis and bone resorption during staphylococcal osteomyelitis. We determined that protein A plays a critical role in osteoclast differentiation and activation by initiating TNFR1 and EGFR mediated signaling. Moreover, we demonstrated that protein A significantly contributes to increased osteoclast differentiation and activation as well as cortical bone destruction during the course of disease using experimental models of osteomyelitis. Our findings strongly suggest targeting protein A and TNFR1 as an adjunctive strategy to control bone damage during the initial course of S. aureus osteomyelitis.